Valuation: Stille AB

Market Cap 243.06Cr 25Cr 22Cr 20Cr 19Cr 36Cr 2.4TCr 36Cr 95Cr 1.18TCr 95Cr 93Cr 4.1TCr P/E 2026 *
27.1x
P/E 2027 * 22.6x
Enterprise Value 234.28Cr 24Cr 21Cr 20Cr 18Cr 34Cr 2.32TCr 35Cr 92Cr 1.14TCr 91Cr 89Cr 3.95TCr EV / Sales 2026 *
3.3x
EV / Sales 2027 * 2.87x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.74%
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Director/Board Member 62 01/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%-8.33% - - 25Cr
+0.12%+1.54%-34.88%-50.65% 1.38TCr
+3.14%+9.42%+71.13%+118.32% 439.43Cr
-0.81%+1.49%+316.86%+206.93% 339.54Cr
+0.18%-4.19%-30.44%-33.31% 237.64Cr
+2.49%+0.92%-43.08%-68.61% 189.38Cr
+0.31%-3.55%-28.82%-28.98% 183.3Cr
-0.75%-2.94%-4.35%-22.35% 129.99Cr
+1.18%+0.59%+27.61%+34.65% 98Cr
+1.40%+0.23%-17.80%-20.37% 93Cr
Average +0.35%-0.90%+28.47%+15.07% 343.46Cr
Weighted average by Cap. +0.61%+0.04%+22.80%+7.99%

Financials

2026 *2027 *
Net sales 71Cr 7.35Cr 6.44Cr 5.94Cr 5.48Cr 10Cr 701.36Cr 11Cr 28Cr 345.64Cr 28Cr 27Cr 1.2TCr 78Cr 8.09Cr 7.09Cr 6.54Cr 6.04Cr 11Cr 771.99Cr 12Cr 31Cr 380.45Cr 30Cr 30Cr 1.32TCr
Net income 9.45Cr 97.98L 85.76L 79.13L 73.05L 1.39Cr 93Cr 1.41Cr 3.71Cr 46Cr 3.68Cr 3.6Cr 159.58Cr 11Cr 1.11Cr 97.56L 90.02L 83.11L 1.58Cr 106.3Cr 1.6Cr 4.22Cr 52Cr 4.18Cr 4.09Cr 181.53Cr
Net Debt -8.77Cr -90.91L -79.58L -73.43L -67.79L -1.29Cr -87Cr -1.31Cr -3.44Cr -43Cr -3.41Cr -3.34Cr -148.07Cr -19Cr -1.94Cr -1.7Cr -1.56Cr -1.44Cr -2.74Cr -184.8Cr -2.79Cr -7.33Cr -91Cr -7.27Cr -7.12Cr -315.59Cr
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-